Smoking and reverse cholesterol transport: evidence for gene-environment interaction by Kaprio, Jaakko et al.
Clinical Genetics 1989: 36: 266-268 Short Quick Report 
Smoking and reverse cholesterol 
transport: evidence for gene- 
environment interaction 
JAAKKO KAPRIO', ROBERT E. ~ R E L L ' ,  BRUCE A. K O m '  AND CHARLES F. Smo' 
'Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan; 
'Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota; 
and 'Human Genetics Division, Graduate School of Public Health, University of Pittsburgh, 
Pittsburgh, Pennsylvania. USA 
Received 26 May, acceptedfor publication 27 May 1989 
Lipid metabolism, like all other life proces- 
ses, is determined by genetic factors, en- 
vironmental influences and their joint ac- 
tion. In quantitative genetics we usually 
model this process as the linear effects of 
genes, environment and their interactions. 
Recently Kondo et al. (1989) reported that 
DNA polymorphisms at the locus for hu- 
man cholesteryl ester transfer protein 
(CETP) were associated with interindividual 
differences in plasma levels of apolipoprote- 
in A-I. The genetic effect was found in non- 
smokers only. We report here another ex- 
ample of the role of gene-environment inter- 
action in determining the components of 
lipid metabolism. 
We have examined the impact of a poly- 
morphic structural variation of a candidate 
gene, Apolipoprotein (apo) H, on nine lipid 
and apolipoprotein phenotypes (Kaprio et 
al. 1989). Apo H has recently been assigned 
to the class of apolipoproteins, but its physi- 
ological role is still poorly understood. 
Structural heterogeneity of apo H has re- 
cently been determined (Kamboh et al. 
1988) and three common alleles of the struc- 
tural gene coding for the protein have been 
observed in Caucasians. 
We identified 567 unrelated adults aged 
26-62 from the Rochester Family Heart 
Study (Moll et al. 1989, Turner et al. 1989). 
After excluding persons (n = 72) using medi- 
cations that may influence plasma lipid 
levels and those who had not been geno- 
typed for apo H (n = 1 S), 480 persons (240 
men, 140 women) formed the sample for 
analysis. Ninety-two were current smokers 
and 388 had never smoked or were former 
smokers. 
We found (Kaprio et al. in preparation) 
that smoking has a significant effect on 
HDLcholesterol, apo A-I and apo A-I1 
levels (adjusted for date of assay, age, age2, 
weight and height) in men and women. As 
the apo H polymorphism showed significant 
effects after each phenotype was also adjust- 
ed for smoking status, we decided to test 
for an interaction between apo H genotypes 
and smoking. The rarer genotypes of apo H 
were combined in this analysis to create two 
groups: genotype apo H 2-2 (n=390) and 
all others (n = 90). HDL-cholesterol, apo A- 
I and apo A-I1 values were adjusted by lin- 
ear regression for date of assay, age, age', 
weight and height for each gender separ- 
ately. A general linear model (SAS Institute 
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Inc. 1985) was used with three independent 
variables: smoking status (current vs non- 
current), genotype (apo H 2-2 vs. others) 
and gender to test for main effects and inter- 
actions. Results for the analysis of apo A- 
I1 are shown in Table 1. The three-way inter- 
action of gender, smoking and genotype was 
non-significant. Thus the three two-way in- 
teractions could be examined. Only the in- 
teraction of genotype and smoking was 
found to be statistically significant at the 
0.05 level of probability. The main effects 
were significant for genotype and smoking. 
The effect of smoking was to decrease apo- 
A11 levels in subjects with the apo H 2- 
2 genotype, but not in subjects with other 
genotypes. For HDL and apo-AI, the inter- 
actions of genotype and smoking were not 
statistically significant. 
Apo A-I and apo A-I1 are the major pro- 
tein components of HDL, which partici- 
pates in the 'reverse cholesterol transport' 
of excess cholesterol from the extrahepatic 
tissues to the liver for catabolism. CEPT is 
also involved in this process. Smoking is 
known to depress levels of HDL-cholesterol 
and apo A-I (Berg et al. 1979), as was found 
in the present study. Our study and the re- 
port of Kondo et al. (1989) suggest that the 
effects of smoking are dependent on the 
genotype of certain genes coding for pro- 
teins participating in reverse cholesterol 
transport. We can only speculate on the 
mechanism for this process, because smok- 
ing affects many metabolic parameters 
(Laustiola et al. 1988). There may be chemi- 
cal components of tobacco smoke that di- 
rectly modify the composition or structure 
of HDL-particles. Alternatively smoking 
may alter the physicochemical milieu, which 
indirectly affects the metabolic pathways 
that are involved. It is known that smoking 
has a significant impact on quantitative 
levels of a number of plasma proteins in- 
volved in determining cardiovascular dis- 
ease risk (Berg et al. 1979, Wilhelmsen et al. 
Table 1 
Interaction of smoking with apo H genotypes on levels of apo A-11. Mean levels of apo A-ll (mgl 
dl) by smoking status and apo-H genotype (2-2 vs non:2-2) in unrelated Individuals from Rochester, 
Minnesota. (N of subjects in parentheses) 
Men Women Total 
Smoking Genotype Genotype Genotype 
status 22 Non-22 22 Non-22 22 Now22 
Smoker 32.25 38.21 31.55 33.13 31.94 34.50 
(39) (8) (31) (10) (70) (18) 
Non-smoker 34.91 34.12 34.34 35.25 34.64 34.71 
(159) (34) (161) (38) (320) (72) 
Annlysls ot variance 
Source Partial Sum of Squares F-value P-value 
~ 
Mnin effects: 
Smoking 84.9 4.42 0.036 
Genotype 91.1 4.74 0.wO 
Gender 29.6 1.54 0.22 
Two-way internctions: 
Genotype by smoking 
Smoking by gender 
Genotype by gender 
84.0 4.37 0.037 
53.9 2.81 0.09 
1.32 0.07 0.79 
Thresway Interectlon: 
Genotype by gender by smoking 47.3 2.46 0.12 
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1984). It will be of interest to determine 
whether these effects are genotype specific. 
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